SF Healthcare Week: Soleno Therapeutics' Chairman & CEO Anish Bhatnager discusses the launch of its Prader-Willi syndrome therapy VYKAT XR
He describes the launch, physician and patient feedback, and responds in his own words to short seller criticism.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.